Sort
40,608 grants matching “prostate cancer”
Long-term prediction of prostate cancer death from kallikreins measured in blood
$351,869Hans Gãsta Lilja · Sloan-Kettering Inst Can Research · R33 · FY2010 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$351,860David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Therapeutic targeting steroid sulfatase for advanced prostate cancer
$351,830Allen C Gao · University Of California At Davis · R01 · FY2023 · CA
Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis
$351,783Jacques Eduardo Nor · University Of Michigan At Ann Arbor · R01 · FY2006 · DE
Targeting AR variants in advanced prostate cancer
$351,775Allen C Gao · University Of California At Davis · R01 · FY2023 · CA
Targeting AR variants in advanced prostate cancer
$351,775Allen C Gao · University Of California At Davis · R01 · FY2022 · CA
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
$351,758Lorelei Mucci · Brigham And Women'S Hospital · R01 · FY2010 · CA
CALGB
$351,751Ohio State University · U10 · FY2001 · CA
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
$351,731Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
$351,731Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
$351,731Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
$351,731Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
$351,731Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Prostate Cancer Recurrence: models and mechanisms
$351,723Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2014 · CA
An androgen receptor coactivator regulated in prostate
$351,713Susan K. Logan · New York University School Of Medicine · R01 · FY2009 · CA
An androgen receptor coactivator regulated in prostate
$351,713Susan K. Logan · New York University School Of Medicine · R01 · FY2010 · CA
An androgen receptor coactivator regulated in prostate
$351,713Susan K. Logan · New York University School Of Medicine · R01 · FY2008 · CA
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$351,711Xiaolin Zi · University Of California-Irvine · R01 · FY2023 · CA
Biospecimen Acquisition, Processing and Classification Unit
$351,703Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · U2C · FY2022 · CA
Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target
$351,697Daret K St Clair · University Of Kentucky · R01 · FY2016 · CA
Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer
$351,691Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Corepressor Function of Steroid Receptor Coactivator-3 in Breast Cancer
$351,691Ray-Chang Wu · George Washington University · R01 · FY2019 · CA
Developing silastic-silicone for the local delivery of hormonal therapy to prevent and treat breast cancer
$351,691Pamela N Munster · University Of California, San Francisco · R01 · FY2019 · CA
Effects of extracellular vesicles on miRNA activity in the skin
$351,685My Georgia Mahoney · Thomas Jefferson University · R01 · FY2019 · AR
PDGF D and Prostate Cancer Bone Metastasis
$351,673Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2016 · CA